학술논문

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
Document Type
Article
Source
In Clinical Lung Cancer November 2021 22(6):541-548
Subject
Language
ISSN
1525-7304